Skip to content
Skip to content

Paper evidence version 3

Content hash: sha256:15a16627e1446d7af1ad08a42aed83c31a14a43fd1780d3a94d17f3f30045e89

Integrity: current

Publication status: published

Source-reported research findings

AI-extracted — pending human review. These findings retain the studied context and are not pooled treatment estimates.

Single study

PMID 39498904: Computerized Mental Performance Assessment System (COMPASS)

  • AI-extracted — pending human review
  • Extraction status: machine extracted. Source status is not human clinical review.
  • Publication status: published. Record review status: not reviewed.
  • Not poolable: one source-reported result, not a pooled treatment estimate.

Authors reported a direction only for episodic memory, working memory, and accuracy of attention (Computerized Mental Performance Assessment System (COMPASS)): favours the studied intervention.

Reported p < 0.05.

  • Studied route/context: orally.

adults with self-reported cognitive and energy problems; prospective, randomized, placebo-controlled study. Ashwagandha (Withania somnifera) root extract (ARE) 600 mg/day versus identical placebo. episodic memory, working memory, and accuracy of attention (Computerized Mental Performance Assessment System (COMPASS)) at 8 week baseline.

That’s the gist — a fine place to stop. This describes the studied groups, not personal suitability.

Read the full paper explanation →Original source · Bring into My Profile

Results

JSON provenance →